SOX9 and lung adenocarcinoma: Recent studies have further shown that SOX9 suppresses antitumor immunity in KRAS-driven lung adenocarcinoma (16), is correlated with immune-suppressive pathways across cancers (15), and promotes an immunosuppressive microenvironment in gastric cancer (13).